Beyond Genomics Becomes BG Medicine

Beyond Genomics has announced its name change to BG Medicine. The company also announced the appointment of Pieter Muntendam as its new president to lead the company's business operations and strategy. BG Medicine's new name and new leadership reflect the decision to focus on high-value drug development applications of its proprietary Systems Pharmacology platform that is based on the scientific advances in the nascent Systems Biology field.

Big News Network (http://feeds.bignewsnetwork.com/redir.php?jid=fa218e62349f6d05&cat=6dcd932030878143)